Interestingly, radioresistance of KEAP1/NFE2L2 mutated NSCLC cells could be overcome by treatment with a glutaminase inhibitor resulting in depletion of glutathione [14]. This evidence concerns the gene GLS and non-small cell lung carcinoma.